pharmaphorum

SEPTEMBER 18, 2020

Between 2001 and 2005, Nexium netted AstraZeneca approximately $14.4 AstraZeneca’s first acquisition following its creation was of KuDOS Pharmaceuticals, a UK biotech company, for £120 million in 2005. In June 2007, AstraZeneca completed the acquisition of vaccine maker MedImmune, buying its drug-development pipeline for $15.2

Vaccines 116

Vaccines Pharmaceutical Companies Pharmaceutical Companies Drug Development 116

European Pharmaceutical Review

AUGUST 10, 2022

countries with manufacturing capacity for diagnostics, vaccines and therapeutics. Monkeypox is a disease caused by a zoonotic orthopoxvirus (the monkeypox virus) with similar but less severe symptoms to smallpox – a related disease eradicated through vaccination campaigns by May 1980 – including a rash and fever. But what is monkeypox?

Vaccines 96

Vaccines Immunization Immunity Labelling 96

pharmaphorum

MARCH 14, 2022

Janssen’s Roz Bekker, VP Commercial Strategy for Infectious Diseases & Vaccines at Janssen EMEA, looks at how COVID-19 has reinforced the value of connecting with people, and how healthcare systems need ongoing reform to deliver more holistic, human-centric care. The connecting effect of COVID-19.

Vaccines 98

Vaccines Pharmaceutical Companies Pharmaceutical Companies Hospitals 98

European Pharmaceutical Review

SEPTEMBER 22, 2023

Active anti-Abeta immunotherapies In the 2000s, the concept of active immunotherapy targeting Abeta in Alzheimer’s patients was assessed with the ELAN vaccine (AN1792), consisting of full-length aggregated Abeta 1-42 peptide mixed with the QS21 adjuvant. 8 However, as this trial was not placebo-controlled, conclusions are difficult to draw.

Immunization 97

Immunization Immunity Vaccines Communication 97

pharmaphorum

JANUARY 27, 2023

The recent reversal of China’s “zero Covid” policy, at a time when the country still lacks optimal vaccine coverage, has also created another unknown, in terms of global supply and demand forecasting. He previously held regional leadership roles at Sandoz between 2005 and 2010.

Packaging 105

Packaging Biosimilars Vaccines 105

pharmaphorum

OCTOBER 12, 2022

Del Bourgo highlights that genomic treatments work in a similar way to mRNA, which has been used in COVID-19 vaccines. Just as mRNA and COVID-19 showed the world that it’s possible to develop vaccines much faster, Del Bourgo explains, AI can help us develop new genomic medicines in a more efficient way.

Drug Development 105

Drug Development Immunization Immunity Vaccines 105

RX Note

NOVEMBER 4, 2023

Prevention Because the risk of severe complications from herpes zoster is more likely in older people, those aged over 60 years might consider zoster vaccine , which can reduce the incidence of herpes zoster by half.

Vaccines 40

Vaccines Community Pharmacies 40

Express Pharma

JULY 10, 2024

India has traced a journey of grit and glory to emerge as a major supplier of generic drugs and vaccines globally. IBER Report 2023 divulges, “The biopharma vaccines (non-COVID alone) market makes a significant daily contribution of approximately $38 million. Today, it is a key player in the global pharma landscape. billion monthly.”

Vaccines 96

Vaccines Drug Development Process Improvement Biosimilars 96

Pharmaceutical Technology

OCTOBER 28, 2022

Quality by design (QbD) is a concept introduced into the pharmaceutical regulatory lexicon in 2005. For example, the Covid-19 pandemic brought messenger ribonucleic acid (mRNA) vaccines into international prominence. Because mRNA is highly unstable, these vaccines have had to be stored and/or transported at -80°C to avoid degradation.

Biosimilars 52

Biosimilars Vaccines Drug Development Documentation 52

Pharma in Brief

AUGUST 3, 2023

Background The prior version of the Distinction Guidance was last updated in August 2005 (the Old Guidance ) and did not adequately address the evolution of advertising activities since that time, including online advertising, search engine marketing, and social media activities.

Labelling 52

Labelling Packaging Vaccines 52

Pharmaceutical Technology

JULY 23, 2008

It has boosted anti-tumour research by 60% since 2005, at a cost of $1.6bn, in the hope of increasing the share of company sales attributed to cancer drugs from the current level of 5% “There are a lot of patients that are suffering,” said Pfizer chief executive Jeffrey Kindler.

Pharmaceutical Companies 40

Pharmaceutical Companies Pharmaceutical Companies Compounding Biosimilars 40

PharmaShots

APRIL 13, 2023

The company also granted exclusive marketing rights to Meda for Cibacen and Cibadrex in major EU markets for $0.13B In the year 2005, Bayer’s sales depicted an increase of 18%, attributable mainly due to its consumer health business acquired from Roche Abbott achieved a total revenue of $1.4B compared to 2015. to the total revenue.

Biosimilars 40

Biosimilars Vaccines Pharmaceutical Companies Pharmaceutical Companies 40

Pharma in Brief

JANUARY 10, 2024

The Guidance was last updated in 2005. It now contemplates IT platforms ( e.g. , social media) and applies to drugs for use in humans as well as medical devices, natural health products, biologics, vaccines, and animal health products. Rare disease strategy.

Drug Pricing 52

Drug Pricing Documentation Biosimilars Vaccines 52

PharmaShots

JANUARY 31, 2023

Funding Value: $7M Founded Year: 2005 No. The Company's premier line of smart safety syringes, Sharps Provensa, prevents accidental needlestick injuries, prevents needle reuse, and minimizes drug and vaccine waste—all while maintaining the intuitive simplicity of conventional syringes. The company bagged its $6.3M

Vaccines 40

Vaccines Immunization Immunity Diabetes 40

PharmaShots

MAY 23, 2023

Stock Exchange: TYO With focus areas extending to the discovery and development of biopharma products, AnGes is dedicated to developing genetic medicines and therapeutic vaccines for intractable or rare diseases. Approved Cell and Gene Therapy: Collategene Founded Year: 1999 Total Employees: ~140 Headquarters: Osaka, Japan Market Cap: $162.8M

Diabetes 58

Diabetes Immunity Immunization Pharmaceutical Companies 58

PharmaShots

MARCH 9, 2023

Designation: Executive Chairperson Award & Nominations: Kiran has been honored with two of India’s prestigious civilian awards: Padma Shri (1989) and Padma Bhushan (2005). Designation: Global Head Previous company: Merck Global Vaccines (2 yrs. Birthplace: Romana was born and brought up in Toronto.

Clinical Pharmacology 40

Clinical Pharmacology Immunization Immunity Pharmaceutical Companies 40

Express Pharma

SEPTEMBER 11, 2023

In the case of vaccines and anti-neoplastic medication, it requires high standards and more capital investments, resulting in the lowest brand creation, with only five and seven brands per formulation, respectively. Vitamins/minerals and sex stimulants display higher brand creation.

Generic Medicine 69

Generic Medicine Diabetes Immunity Immunization 69

pharmaphorum

NOVEMBER 23, 2021

Entrepreneur brothers Thomas and Andreas Struengmann – who hold a stake in COVID-19 vaccine developer BioNTech – have history in the generics sector, having sold drugmaker Hexal to Sandoz in 2005, said Reuters. It also said other private equity groups have taken an interest in Sandoz.

Vaccines 97

Vaccines 97

Pharmaceutical Technology

APRIL 27, 2023

The successful development and deployment of the mRNA-based COVID-19 vaccines has catalysed the biopharma industry and paved the way to expand this drug modality to new therapeutic areas. Excluding vaccines, there are five mRNA therapeutic products in clinical trial development as of November 2022.

Vaccines 52

Vaccines Drug Development Documentation Communication 52

European Pharmaceutical Review

AUGUST 29, 2024

5 Preventing spread of the mpox virus To help prevent more cases of the virus, the CDC recommended that individuals who have had exposure to the virus and those at risk of infection are given two doses of biotech Bavarian Nordic’s vaccine JYNNEOS ® (MVA-BN).

Vaccines 98

Vaccines Immunization Immunity Pharmaceutical Companies 98

pharmaphorum

JANUARY 21, 2021

Woodcock has most recently been working with the Operation Warp Speed coronavirus vaccine and drug project started by the Trump administration. She held several other roles at CBER before being named as director of the FDA’s Center for Drug Evaluation and Research in 1994 and staying in that role until 2005.

Medical Schools 105

Medical Schools Vaccines 105